枳实薤白桂枝汤联合西药治疗寒凝气滞兼痰瘀证不稳定型心绞痛临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R541.4

基金项目:


Clinical Study on Zhishi Xiebai Guizhi Decoction Combined with Western Medicine for Unstable Angina with Syndrome of Qi Stagnation due to Congealing Cold Combined Phlegm Stasis
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察枳实薤白桂枝汤联合常规西药治疗寒凝气滞兼痰瘀证不稳定型心绞痛(UA) 的临床疗 效。方法:回顾性分析218 例寒凝气滞兼痰瘀证UA 患者的临床资料,根据治疗方案的不同分为治疗组106 例 及对照组112 例。对照组给予硫酸氢氯吡格雷片、阿司匹林肠溶片、瑞舒伐他汀钙片治疗,治疗组在对照组基 础上联合枳实薤白桂枝汤治疗,疗程均为14 d。比较2 组临床疗效、寒凝气滞兼痰瘀证中医证候评分、心绞痛 症状评分及不良反应发生率。结果:治疗组总有效率为88.68%,对照组为75.89%,2 组比较,差异有统计学 意义(P<0.05)。治疗前,2 组四肢不温、怠倦乏力、痰涎气短、心悸不安等中医证候评分比较,差异无统计 学意义(P>0.05);治疗后,2 组上述各项评分均较治疗前降低(P<0.05),且治疗组各项评分均低于对照 组(P<0.05)。治疗前,2 组胸胁胀闷、胸痛彻背、心绞痛分级评分比较,差异无统计学意义(P>0.05);治 疗后,胸胁胀闷、胸痛彻背、心绞痛分级评分均较治疗前降低(P<0.05),且治疗组上述各项评分均低于对照 组(P<0.05)。治疗组不良反应发生率为22.64%,对照组为28.57%,2 组比较,差异无统计学意义(P> 0.05)。结论:枳实薤白桂枝汤联合常规西药治疗寒凝气滞兼痰瘀证UA 疗效显著,可有效缓解患者中医证候 及心绞痛症状,且无增加药物的不良反应。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Zhishi Xiebai Guizhi Decoction combined with routine western medicine for unstable angina (UA) with syndrome of qi stagnation due to congealing cold combined phlegm stasis. Methods:Clinical data of 218 cases of UA patients with syndrome of qi stagnation due to congealing cold combined phlegm stasis were retrospectively analyzed and divided into the treatment group and the control group according to different treatment schemes, with 106 and 112 cases in each group respectively. The control group was treated with Clopidogrel Bisulfate Tablets, Aspirin Enteric- Coated Tablets,and Rosuvastatin Calcium Tablets,and the treatment group was additionally treated with Zhishi Xiebai Guizhi Decoction based on the treatment of the control group. Both groups were treated for 14 days. Clinical effects, traditional Chinese medicine (TCM) syndrome scores of qi stagnation due to congealing cold combined phlegm stasis, symptom scores of angina, and the incidence of adverse reactions were compared between the two groups. Results: The total effective rate was 88.68% in the treatment group and 75.89% in the control group, the difference being significant (P<0.05). Before treatment,there was no significant difference being found in the comparison of TCM syndrome scores of lack of warmth in the limbs,fatigue and lack of strength,phlegm-drool and short breath,and palpitations between the two groups (P>0.05);after treatment,the above scores in the two groups were decreased when compared with those before treatment (P<0.05),and each score in the treatment group was lower than that in the control group (P<0.05). Before treatment,there was no significant difference being found in the comparison of grading scores of distention and oppression in the chest and rib- side, chest pain spreading to the back,and angina between the two groups (P>0.05);after treatment,the above grading scores in the two groups were decreased when compared with those before treatment (P<0.05),and each score in the treatment group was lower than that in the control group (P<0.05). The incidence of adverse reactions was 22.64% in the treatment group and 28.57% in the control group,there being no significant difference being found between the two groups (P> 0.05). Conclusion: Zhishi Xiebai Guizhi Decoction combined with routine western medicine has a significant curative effect in the treatment of UA with syndrome of qi stagnation due to congealing cold combined phlegm stasis and can effectively relieve TCM syndromes and angina symptoms,and there were no adverse reactions that increased the medication.

    参考文献
    相似文献
    引证文献
引用本文

刘嘉宁,张雅萍.枳实薤白桂枝汤联合西药治疗寒凝气滞兼痰瘀证不稳定型心绞痛临床研究[J].新中医,2023,55(20):36-39

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-10-27
  • 出版日期:
文章二维码